Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · IEX Real-Time Price · USD

7.52

-0.84 (-10.05%)

At close: Jul 2, 2024, 4:00 PM

7.50

-0.02 (-0.27%)

After-hours: Jul 2, 2024, 7:03 PM EDT

Atara Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-276.13	-228.3	-340.14	-306.62	-290.98	Upgrade
Depreciation & Amortization	16.62	14.57	11.29	9.79	8.03	Upgrade
Share-Based Compensation	45.39	53.84	53.87	51.35	51.7	Upgrade
Other Operating Activities	21.14	-110.53	54.46	64.72	-4.38	Upgrade
Operating Cash Flow	-192.98	-270.43	-220.52	-180.76	-235.63	Upgrade
Capital Expenditures	-1.2	90.57	-10.58	-4.51	-5.57	Upgrade
Change in Investments	125.06	112.38	32.84	-116.22	66.03	Upgrade
Investing Cash Flow	123.87	202.96	22.26	-120.73	60.46	Upgrade
Share Issuance / Repurchase	2.14	21.89	98.7	422.97	188.62	Upgrade
Debt Issued / Paid	-0.95	30.09	-0.25	-0.39	-0.49	Upgrade
Other Financing Activities	0.82	1.11	5.5	4.99	0.66	Upgrade
Financing Cash Flow	2.01	53.08	103.94	427.57	188.79	Upgrade
Net Cash Flow	-67.1	-14.39	-94.32	126.09	13.62	Upgrade
Free Cash Flow	-194.18	-179.86	-231.1	-185.27	-241.2	Upgrade
Free Cash Flow Margin	-2264.96%	-282.92%	-1136.19%	-	-	Upgrade
Free Cash Flow Per Share	-45.83	-44.09	-61.68	-62.62	-117.53	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).